Passage BIO, Inc. (PASG)
2025-06-30 | ||||
|---|---|---|---|---|
| Other income (expense), net | 949 | |||
| Research and development | 5,814 | |||
| General and administrative | 4,520 | |||
| Loss from operations | -10,334 | |||
| Net loss | -9,385 | |||
| Comprehensive loss | -9,385 | |||
| Earnings per share, basic | -2.96 | |||
| Earnings per share, diluted | -2.96 | |||
| Weighted average number of shares outstanding, basic | 3,168,933 | |||
| Weighted average number of shares outstanding, diluted | 3,168,933 | |||